2022-03-042022-03-042005Ersoy, A. vd. (2005). "Primary central nervous system lymphoma in a renal transplant recipient with Bardet-Biedl syndrome". Transplantation Proceedings, 37(10), 4323-4325.0041-1345https://doi.org/10.1016/j.transproceed.2005.10.121https://www.sciencedirect.com/science/article/pii/S0041134505012923https://pubmed.ncbi.nlm.nih.gov/16387110/http://hdl.handle.net/11452/24821Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder. End-stage renal failure has been reported as the most frequent cause of death in this disorder. There are few reports of kidney transplantation in these patients. Renal transplant patients are known to be at increased risk for the development of malignancies. Although a few patients with BBS have been described to develop malignant disease, there was no previous association with lymphoma. We report a 20-year-old patient in whom primary central nervous system lymphoma was diagnosed 20 months after renal transplantation.eninfo:eu-repo/semantics/closedAccessImmunologySurgeryTransplantationCancerObesityDiseaseFormAdultAntineoplastic agentsBardet-biedl syndromeCentral nervous system neoplasmsCombined modality therapyCreatinineFemaleHumansKidney failure, chronicKidney transplantationLymphomaMethotrexatePostoperative complicationsArticle0002344129000462-s2.0-2954444538543234325371016387110ImmunologyTransplantationSurgeryBardet Biedl Syndrome; Postaxial Polydactyly; Alstrom SyndromeDaclizumabMethotrexateMycophenolic acid 2 morpholinoethyl esterParacetamolPrednisoloneRapamycinSteroidAdultArticleAutosomal recessive inheritanceBardet biedl syndromeBrain lymphomaCase reportCerebrospinal fluidChemotherapyComputer assisted tomographyCreatinine blood levelDisease courseFemaleFollow upGraft versus host reactionHumanImmunohistochemistryKidney transplantationPatientPriority journalRecipientRisk assessment